Clinical Research, Pharma & Healthcare FinancingOno Licenses Sapablursen from Ionis for Polycythemia VeraBusiness WireMarch 12, 2025March 18, 2025 by Business WireMarch 12, 2025March 18, 2025062 Ono Pharmaceutical Co., Ltd. announced that it has entered into a license agreement with Ionis Pharmaceuticals, Inc. for sapablursen, an investigational RNA-targeted medicine for the...
